The U.S. Food and Drug Administration grants orphan drug designation to ISB 2001 for the treatment of multiple myeloma NEW YORK, July 7, 2023 /PRNewswire/ — Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager…